National Medical Care Company (TADAWUL:4005)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
116.40
+0.60 (0.52%)
Mar 3, 2026, 3:18 PM AST

TADAWUL:4005 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,6001,2941,082917.93845.38
Revenue Growth (YoY)
23.71%19.59%17.85%8.58%4.50%
Cost of Revenue
1,254845.11714.93630.99601.08
Gross Profit
346.36448.58366.85286.95244.3
Selling, General & Admin
-167.64124.5393.0879.09
Other Operating Expenses
--6.33-4.03-8.35-8.19
Operating Expenses
-194.03120.1389.6879.9
Operating Income
346.36254.55246.72197.27164.4
Interest Expense
--22.74-3.5--
Interest & Investment Income
-19.4821.371.24-
EBT Excluding Unusual Items
346.36251.29264.59198.5164.4
Legal Settlements
-42.34---
Pretax Income
346.36293.63264.59198.5164.4
Income Tax Expense
27.89-4.5423.6728.4328.04
Net Income
318.47298.16240.93170.07136.36
Net Income to Common
318.47298.16240.93170.07136.36
Net Income Growth
6.81%23.76%41.66%24.73%40.18%
Shares Outstanding (Basic)
4545454545
Shares Outstanding (Diluted)
4545454545
Shares Change (YoY)
-0.23%-0.18%---
EPS (Basic)
7.136.665.373.793.04
EPS (Diluted)
7.136.665.373.793.04
EPS Growth
7.05%23.98%41.66%24.73%40.18%
Free Cash Flow
153.97136.63412.73185.8361.61
Free Cash Flow Per Share
3.453.059.204.141.37
Dividend Per Share
-2.0002.0001.0001.000
Dividend Growth
--100.00%--
Gross Margin
21.64%34.67%33.91%31.26%28.90%
Operating Margin
21.64%19.68%22.81%21.49%19.45%
Profit Margin
19.90%23.05%22.27%18.53%16.13%
Free Cash Flow Margin
9.62%10.56%38.15%20.24%7.29%
EBITDA
423.39315.14290.94239.17214.56
EBITDA Margin
26.46%24.36%26.90%26.05%25.38%
D&A For EBITDA
77.0360.644.2241.950.16
EBIT
346.36254.55246.72197.27164.4
EBIT Margin
21.64%19.68%22.81%21.49%19.45%
Effective Tax Rate
8.05%-8.95%14.32%17.06%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.